Endocrinology News

Physicians treating Medicare patients are staring down the barrel of five consecutive years of cuts to their reimbursement rates.

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis, researchers reported.

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of an automated insulin delivery system compared with standard care, according to findings from a new trial.

Midlife women with repeated episodes of heavy or prolonged menstrual bleeding over 6 months were 40% to 60% more likely to report feeling fatigued, underscoring the clinical importance of menstrual history during the menopause transition.

It has been 5 years since the start of the COVID-19 pandemic, which forced many providers to embrace telehealth.

Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a study published in JAMA Network Open.

The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results.

Use of AI in medicine is growing quickly. Clinicians are eager to learn what the technology can do, and speakers at meetings across specialties are envisioning its effects — good and bad — in practice management and patient care.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns.